Imricor Medical Completes First In Vivo Pulsed Field Ablation in Ventricle Under MRI Guidance

MT Newswires Live
Oct 20

Imricor Medical Systems (ASX:IMR) said it completed the first-ever pre-clinical animal study in vivo pulsed field ablation in the ventricle under real-time magnetic resonance imaging (MRI) guidance in an interventional cardiac magnetic resonance imaging laboratory, according to a Monday Australian bourse filing.

The procedure was performed using the firm's second-generation Vision-MR ablation catheter at its iCMR Design Center, validating its technology for integrating pulsed field ablation energy with real-time MRI visualization.

The firm's shares fell 1% in recent trading on Monday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10